Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Brandeis University
- Study ID
- NCT07724275
- Status
- Recruiting
Conditions
- Alcohol Use Disorder
- Digital Health
- Recovery Outcomes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital recovery support services — BEHAVIORALThe primary intervention is the provision of a menu of digital recovery support services (D-RSS) to participants, along with a phone and data plan (if needed) and technical assistance. We have created a menu of D-RSS options that have been vetted by our team as appropriate for a range of recovery goals (e.g., manage emotions, track sobriety, connect with others) and for a range of technological literacy, as well as being culturally relevant or at minimum culturally agnostic. Types of D-RSS presented to participants include mobile applications, websites, and video playlists, all of which relate to and support addiction recovery. Participants also may use other D-RSS that they identify.
Study Details
The goal of this clinical trial is to learn if digital recovery support services (such as smartphone app) help to support alcohol recovery. We focus on a community of Black and African American people with alcohol use disorder (AUD) who receive in-person recovery support services from a recovery community center. Participants will: * Have an initial 2-hour in-person visit with the research team. During this visit, participants will be asked about themselves and their recovery from alcohol problems. They will also learn about digital recovery resources. * Use digital recovery resources on their own for 12 weeks. * Complete a short, weekly survey about their experience using digital recovery resources. * Have a follow-up 1-hour in-person visit where the researcher asks about again about the participants, their recovery and how they felt about using the digital recovery support services.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Jun 13, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2026
- Completion
- May 31, 2027
Study Design
- Enrollment
- 65 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: TAU + DRSSAt the initial in-person visit, participants will complete a structured interview of baseline assessments and will be provided with a menu of digital recovery support services (D-RSS) to participants, technical assistance, and a phone and data plan (if needed). The research team will discuss the D-RSS menu with the participants and guide them through app installation and use. Following the initial visit, it is up to the participants to engage with the D-RSS. We will send a text survey 1 week after the visit, and each week thereafter for 12 weeks, that assesses their engagement with in-person recovery supports, D-RSS, and their current recovery status. The 3-month visit will be scheduled in the week following the last (week 12) text survey, at which participants will meet with research staff for a final in-person assessment.
Primary Outcome Measure
Usability and Acceptability of D-RSS [ Time Frame: At the end of the trial (13 weeks) ]
Central Contacts
- Audrey Hildebrandt781-736-8657
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Detroit Recovery Project | Detroit | Michigan | 48208 | Sharon Reif, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Detroit, MI
Related Studies
- Removing Barriers: Community Partnering for Innovative Solutions to the Opioid CrisisRecruiting · University of Michigan · Ann Arbor, Michigan
- Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver DiseaseRecruiting · University of Wisconsin, Madison · Lansing, Michigan
- Mobile Platform for Optimizing Wellness and Engagement in RecoveryRecruiting · University of Michigan · Ann Arbor, Michigan
- Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use DisorderPHASE3 · Not Yet Recruiting · VA Office of Research and Development · Long Beach, California